Navigation Links
PediaVision to Conduct Spot Demonstrations During American Academy of Ophthalmology Annual Meeting
Date:10/18/2011

LAKE MARY, Fla., Oct. 18, 2011 /PRNewswire/ --WHO:David Melnik, President & CEO of PediaVisionJeff Mortensen, Vice President of PediaVisionWHAT:Will be conducting demonstrations of Spot, a revolutionary new vision screening device, which identifies vision problems in less than one second.WHEN:Wednesday, October 19, Thursday, October 20, Friday October 21 WHY:Spot is a new breakthrough vision screening device that will help children across America.  Spot has an incredibly quick capture time of less than one second which makes screening equally efficient in a physician's office or large-scale public screening. Spot is easily used by anyone when screening children from 6 months through adults.  URGENCY:

There is an on-going and urgent need for Spot.  The U. S. Centers for Disease Control and Prevention (CDC) state that vision disability is the single most prevalent disabling condition among children. Approximately 80 percent(1) of what children learn in their early school years is visual, so if they can't see a teacher's writing on the blackboard, they will struggle.(1)  American Optometric Association
'/>"/>

SOURCE PediaVision
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. PediaVision Announces Record New Orders for Revolutionary New Vision Screening Device, Spot
2. Phosphagenics to Conduct a Phase 1 Transdermal Oxycodone Clinical Trial
3. Tezampanel, TorreyPines Therapeutics Lead Compound, Reduced Muscle Spasticity and Rigidity in Preclinical Study Conducted at University of California, San Diego
4. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
5. Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
6. Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
7. Maine Natural Health Company Conducts Dental Clinical Trial
8. Access Pharmaceuticals to Conduct Conference Call to Update Financial Community
9. Vical Receives NIH Grant for an Immunotherapeutic Herpes DNA Vaccine; Herpes Experts at University of Washington and University of Texas to Conduct Preclinical Development
10. Tibotec Conducts Two Pivotal Phase III Clinical Trials Studying TMC278 in Treatment-Naive Adults with HIV
11. Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Research ... MEMS Devices Medical Market Analysis 2016 - Forecast to 2022" ... The report contains up to date financial data ... analysis. Assessment of major trends with potential impact on the ... analysis of market segmentation which comprises of sub markets, regional ...
(Date:6/23/2016)... 23, 2016 Bracket , a leading clinical ... generation clinical outcomes platform, Bracket eCOA (SM) 6.0, at ... 26 – 30, 2016 in Philadelphia , ... Outcome Assessment product of its kind to fully integrate with ... Bracket eCOA 6.0 is a flexible platform for electronic clinical ...
(Date:6/23/2016)... -- Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in ... . ... ... ... Astellas is ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from PsychTests.com reveals that behind the tendency ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
(Date:6/24/2016)... ... 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida ... their peers for this recognition are considered among the top 2 percent of lawyers ... as members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark ...
(Date:6/24/2016)... ... ... Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair ... hour by 2020 and then adjusting it yearly to increase at the same rate as ... the wage floor does not erode again, and make future increases more predictable. , The ...
Breaking Medicine News(10 mins):